Literature DB >> 23419219

Report of three cases of herpes zoster during treatment with natalizumab.

Yara Dadalti Fragoso, Joseph Bruno Bidin Brooks, Sidney Gomes, Francisco Tomaz Meneses de Oliveira, Paulo Diniz da Gama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23419219      PMCID： PMC6493545          DOI： 10.1111/cns.12067

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN： 1755-5930            Impact factor:   5.243


× No keyword cloud information.
  5 in total

Review 1.  Vaccines in Multiple Sclerosis.

Authors:  Eric M L Williamson; Salim Chahin; Joseph R Berger
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

Review 2.  Disease-modifying therapies and infectious risks in multiple sclerosis.

Authors:  Alexander Winkelmann; Micha Loebermann; Emil C Reisinger; Hans-Peter Hartung; Uwe K Zettl
Journal:  Nat Rev Neurol       Date:  2016-03-04       Impact factor: 42.937

Review 3.  Infection risk in patients on multiple sclerosis therapeutics.

Authors:  Eric M Williamson; Joseph R Berger
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

4.  Varicella zoster-associated retinal and central nervous system vasculitis in a patient with multiple sclerosis treated with natalizumab.

Authors:  Xenia Kobeleva; Florian Wegner; Inez Brunotte; Mete Dadak; Reinhard Dengler; Martin Stangel
Journal:  J Neuroinflammation       Date:  2014-01-30       Impact factor: 8.322

Review 5.  The use of natalizumab for multiple sclerosis.

Authors:  Rachel Brandstadter; Ilana Katz Sand
Journal:  Neuropsychiatr Dis Treat       Date:  2017-06-28       Impact factor: 2.570
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.